Literature DB >> 1319872

Penetration of temafloxacin into body tissues and fluids.

F Sörgel1.   

Abstract

The new fluoroquinolone antimicrobial temafloxacin shows good penetration into a range of body tissues and fluids, after single or repeated oral administration to healthy volunteers and patients undergoing various procedures. Temafloxacin concentrations in respiratory tissues and fluids, nasal secretions, tonsils, prostate, semen, bone and blister fluid were similar to, or greater than, concurrent serum concentrations. Penetration into sinus secretions and cerebrospinal fluid is less marked; nevertheless, temafloxacin concentrations of approximately 2.4 and 1 mg/L, respectively, were achieved. Concentrations of temafloxacin observed in these tissues and fluids exceed the minimum concentrations required to eradicate the majority of bacterial pathogens associated with respiratory infections, tonsillitis, sinusitis, prostatitis, bone infections and meningitis. Since elimination of temafloxacin occurs by the renal route, high concentrations of the drug are also found in the urine. Biliary excretion of temafloxacin accounts for about 3% and leads to high biliary concentrations of the drug.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319872     DOI: 10.2165/00003088-199200221-00010

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  10 in total

1.  Pharmacokinetics of temafloxacin in humans after single oral doses.

Authors:  G R Granneman; P Carpentier; P J Morrison; A G Pernet
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers.

Authors:  F Sörgel; K G Naber; U Jaehde; A Reiter; R Seelmann; G Sigl
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

Review 3.  Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.

Authors:  F Sorgel; K G Naber; M Kinzig; G Mahr; P Muth
Journal:  Am J Med       Date:  1991-12-30       Impact factor: 4.965

4.  Concentrations of temafloxacin in serum and bronchial mucosa.

Authors:  D R Baldwin; L Wilkinson; J M Andrews; J P Ashby; R Wise; D Honeybourne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

5.  The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.

Authors:  K Nye; Y G Shi; J M Andrews; J P Ashby; R Wise
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

Review 6.  Metabolism of gyrase inhibitors.

Authors:  F Sörgel
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

7.  Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.

Authors:  F Sorgel; R Metz; K Naber; R Seelmann; P Muth
Journal:  J Antimicrob Chemother       Date:  1988-10       Impact factor: 5.790

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

Review 9.  [Enoxacin--comparative pharmacokinetics and tissue penetration].

Authors:  F Sörgel; K G Naber; R Metz; A Morgenroth
Journal:  Infection       Date:  1989       Impact factor: 3.553

Review 10.  Pharmacokinetic disposition of quinolones in human body fluids and tissues.

Authors:  F Sörgel; U Jaehde; K Naber; U Stephan
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

  10 in total
  2 in total

Review 1.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 2.  The quinolones. An overview of their pharmacology.

Authors:  A Fitton
Journal:  Clin Pharmacokinet       Date:  1992       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.